NCT01165645View on ClinicalTrials.gov

Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

December 14, 2011

Conditions
Hodgkin LymphomaStage I Adult Hodgkin LymphomaStage II Adult Hodgkin LymphomaStage III Adult Hodgkin LymphomaStage IV Adult Hodgkin Lymphoma
Interventions
DRUG

lopinavir

Given orally

DRUG

ritonavir

Given orally

GENETIC

polymerase chain reaction

Correlative studies

OTHER

flow cytometry

Correlative studies

OTHER

enzyme-linked immunosorbent assay

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER